OpenLegislation

Regulation 2 Amendment of the Misuse of Drugs Regulations 2001

Original text. Later amendments are not shown.

(1)

The following amendments are made to the Misuse of Drugs Regulations 2001f1.

(2)

In paragraph 1(a) of Schedule 1 (which specifies controlled drugs subject to the requirements of regulations 14, 15, 16, 18, 19, 20, 23, 26 and 27)—

(a)

after “Bromazolam (8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)” insert “Brorphine”;

(b)

after “Bufotenine” insert “Butonitazene”;

(c)

after “Clonazolam (6-(2-Chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)” insert “Clonitazene”;

(d)

after “Concentrate of poppy-straw” insert “Cumyl-PeGaClone”;

(e)

after “3-Dimethylheptyl-11-hydroxyhexahydrocannabinol” insert—

“Diphenidine

Ephenidine

Ethyleneoxynitazene”;

(f)

after “Etizolam” insert—

“Etodesnitazene (etazene)

Etonitazene”;

(g)

after “Flubromazolam (8-Bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)” insert “Flunitazene”;

(h)

after “Isopropylphenidate (IPP or IPPD)” insert “Isotonitazene”;

(i)

after “Methcathinone” insert “Methoxyphenidine”;

(j)

after “Metizolam (4-(2-Chlorophenyl)-2-ethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4] diazepine)” insert—

“Metodesnitazene (metazene)

Metonitazene”;

(k)

after “Propylphenidate” insert “Protonitazene”;

(l)

after “1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45)” insert—

“N-Desethyl etonitazene

N-Desethylisotonitazene

N-Desethyl protonitazene”;

(m)

after “4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4’-DMAR)” insert—

“N-Piperidinyl-etonitazene (etonitazepipne)

N-Pyrrolidino-etonitazene (etoniazepyne)

N-Pyrrolidino protonitazene”.

(3)

In paragraph 1 of Schedule 2 (which specifies controlled drugs subject to the requirements of regulations 14, 15, 16, 16A, 18, 19, 20, 21, 23, 26 and 27) omit “Clonitazene” and “Etonitazene”.

(4)

In paragraph 1 of Part 1 of Schedule 4 (which specifies controlled drugs subject to the requirements of regulations 22, 23, 26 and 27) after “Pyrovalerone” insert “Remimazolam”.

Annotations

Footnotes

f1

S.I. 2001/3998, amended by S.I. 2009/3136, 2015/231 and 2017/631. There are other amending instruments, but none are relevant.